COMMUNIQUÉS West-GlobeNewswire

ObsEva R&D Day Showcases Multiple Women’s Health Programs and Outlines Plans for Transition to Commercial Operations
07/12/2018
Clinical Trial Data and Regulatory Progress on Lead Programs Targeting IVF, Endometriosis, and Uterine Fibroids to Transform Company in 2019 GENEVA, Switzerland and BOSTON, Mass. (December 7, 2018) – ObsEva SA (NASDAQ: [...]
Affimed Announces U.S. Registrational Pathway and Updated Clinical Development Plan for AFM13 at R&D Day
07/12/2018
- Company to Pursue Registrational Pathway for Lead Agent AFM13 Monotherapy in Patients with Peripheral T Cell Lymphoma with Potential for Accelerated Approval - - Clinical Studies for AFM13 in Combination with anti-PD1 [...]
Tauriga Sciences Inc. to Register Trademark with USPTO to Support Launch of its Cannabis Infused Chewing Gum Product Line
07/12/2018
New York, NY, Dec. 07, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. ( TAUG ) (“Tauriga” or the “Company”), engaged in building its business through the development, distribution, and licensing of [...]
Tonix Pharmaceuticals Prices $15,000,000 Public Offering
07/12/2018
NEW YORK, Dec. 07, 2018 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company focused on developing pharmaceutical products to treat [...]
Corruption Widespread in Medical Industry, States the Journal of American Physicians and Surgeons
07/12/2018
TUCSON, Ariz., Dec. 07, 2018 (GLOBE NEWSWIRE) -- Of the more than $3 trillion dollars per year spent worldwide on health services, an untold amount is drained through corruption, according to the non-governmental [...]
OrthoPediatrics Corp. Announces Pricing of Offering of Common Stock
07/12/2018
WARSAW, Ind., Dec. 07, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (Nasdaq: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today the pricing of its [...]
Global Blood Therapeutics Prices a $150.0 Million Common Stock Public Offering
07/12/2018
SOUTH SAN FRANCISCO, Calif., Dec. 07, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (Nasdaq: GBT), a clinical-stage biopharmaceutical company determined to discover, develop and deliver innovative [...]
Oxford Immunotec Announces Regulatory Acceptance of T-Cell Select™ in China
07/12/2018
OXFORD, United Kingdom and MARLBOROUGH, Mass., Dec. 07, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company, today announced regulatory acceptance of the T-Cell [...]
Site Visit Planned for December 19, 2018 to Initiate Phase 2 Trial of ProscaVax for Early-Stage Prostate Cancer
07/12/2018
BATON ROUGE, La., Dec. 07, 2018 (GLOBE NEWSWIRE) -- OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" or the "Company"), a clinical-stage biopharmaceutical company engaged in the development of a proprietary [...]
How to Lower Healthcare Costs: Advice to Congress from AAPS President Marilyn Singleton, M.D., J.D.
07/12/2018
TUCSON, Ariz., Dec. 07, 2018 (GLOBE NEWSWIRE) -- Health-related costs have soared from about 5 percent of the average household’s annual spending in 1984 to 8 percent now, writes Marilyn Singleton , M.D., J.D., in the [...]
Re-analysis of CDC Data Suggests Need for Further Investigation on MMR Vaccine and Autism, according to Article in the Journal of American Physicians and Surgeons
07/12/2018
TUCSON, Ariz., Dec. 07, 2018 (GLOBE NEWSWIRE) -- As early as 2001, the Centers for Disease Control and Prevention (CDC) had data showing an increased rate of autism diagnoses in black male schoolchildren in Atlanta who [...]
Prospective Study Demonstrates EndoPredict® Can Guide Chemotherapy Decision For Women with Early-Stage Breast Cancer
07/12/2018
SALT LAKE CITY, Dec. 07, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in personalized medicine, today announced that academic researchers from the Technical University of Munich (TUM) [...]
Biome Grow Signs Massive Provincial Supply Agreement-- CFN Media
07/12/2018
SEATTLE, Dec. 07, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Gala Pharmaceutical Files State License Application for Testing Facility
07/12/2018
IRVINE, Calif., Dec. 07, 2018 (GLOBE NEWSWIRE) -- Gala Pharmaceutical, Inc. (Ticker: GLPH), a robust and burgeoning Analytical testing company, today announced notable progress toward opening its doors and serving its [...]
Myriad Announces Important New Data for Its EndoPredict® Breast Cancer Test Will Be Presented at the 2018 San Antonio Breast Cancer Symposium
07/12/2018
EndoPredict is the Only Test to Answer Three Critical Questions: Risk of Breast Cancer Recurrence, Benefits of Chemotherapy and Who Can Forgo Extended Endocrine Therapy SALT LAKE CITY, Dec. 07, 2018 (GLOBE NEWSWIRE) -- [...]
Physician-Assisted Death and Lifeboat Ethics Pre-empt Oath of Hippocrates, States the Journal of American Physicians and Surgeons
07/12/2018
TUCSON, Ariz., Dec. 07, 2018 (GLOBE NEWSWIRE) -- Physician-assisted suicide (PAS) or physician-assisted death (PAD) are now receiving strong public support, writes Jeffrey Hall Dobken , M.D., M.P.H., in the winter issue [...]
iCAD Announces FDA Clearance of ProFound AI™ for Digital Breast Tomosynthesis
07/12/2018
High-performance, cancer detection technology built on artificial intelligence now available to healthcare facilities in the U.S. New U.S. clearance based on clinical results demonstrating unprecedented improvements in [...]
MediPets CBD Infused Dog Treats Win Prestigious Industry Award
07/12/2018
PotNetwork Holdings subsidiary wins 2018 Pet Industry Recognition Award in Dog Treats Functional Category MIAMI, Dec. 07, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Diamond CBD Inc., a wholly-owned subsidiary of [...]
DIAMEDICA ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING AND NASDAQ LISTING
07/12/2018
MINNEAPOLIS, Dec. 07, 2018 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (“DiaMedica”) (NASDAQ:DMAC) (TSX‑V:DMA), a clinical stage biopharmaceutical company, announced today the pricing of its initial public offering [...]

Pages